Listed by the USPTO as DANIEL, ANTARIUS S
Tech Center 3700 • Art Units: 3783 3791
This examiner grants 52% of resolved cases
Antarius S. Daniel is an examiner in Tech Center 3700 and Art Unit 3783. He has 196 resolved cases and an allowance rate of 52.0 percent. The interview lift is 14.4 percent, suggesting a benefit from interviews compared to the 52.0 percent baseline. This data indicates that while interviews are helpful, they are a part of a successful prosecution strategy for the 196 cases resolved by this examiner.
The median days to allowance is 1276. Top companies include Becton, Dickinson and Company, VANTIS VASCULAR, INC., and Vapocoolshot Inc. These companies are often represented by Knobbe, Martens, Olson & Bear, LLP, SHAY GLENN LLP, and Via LLP. The 1276 median days to allowance provides a benchmark for these firms to use when advising their clients on the expected duration of the patent acquisition process before this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18733281 | ELONGATE INSTRUMENT AND ELONGATE INSTRUMENT GUARD MEMBER COMPATIBILITY | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 17854923 | WOUND CLOSURE SYSTEMS, DEVICES AND METHODS INCORPORATING THERAPEUTIC DEVICES | Final Rejection | Cilag GmbH International |
| 18530925 | SWITCH CHANNEL STAY-ON HEMOSHIELD CONNECTOR | Final Rejection | CareFusion 303, Inc. |
| 17636913 | TUBE SECUREMENT SYSTEM | Non-Final OA | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY |
| 17597990 | ACTIVE MICRONEEDLES FOR ENHANCED PAYLOAD UPTAKE | Non-Final OA | The Regents of the University of California |
| 17273407 | PEDIATRIC CATHETER | Non-Final OA | Vanderbilt University |
| 18111138 | PROTECTIVE COVER | Non-Final OA | The Cleveland Clinic Foundation |
| 18051221 | GUIDE CATHETER EXTENSION SYSTEM FOR REVERSE CONTROLLED ANTEGRADE/RETROGRADE TRACKING & THROMBUS REMOVAL PROCEDURES | Non-Final OA | VANTIS VASCULAR, INC. |
| 16132878 | INTRAVASCULAR DELIVERY SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY INTERVENTION | Non-Final OA | VANTIS VASCULAR, INC. |
| 18115189 | Catheter Component Securement Apparatus and Associated System | Final Rejection | Becton, Dickinson and Company |
| 18093208 | Catheter Adapter with Integrated Adhesive Dispenser | Non-Final OA | Becton, Dickinson and Company |
| 18092592 | Management of Catheters and Accessories During Intravascular Catheter Maintenance | Non-Final OA | Becton, Dickinson and Company |
| 18706198 | DRUG DELIVERY DEVICE, DRUG RESERVOIR UNIT AND SET | Non-Final OA | Sanofi |
| 18035939 | SKIN PATCH DRUG INFUSION SYSTEM | Final Rejection | MEDTRUM TECHNOLOGIES INC. |
| 18182263 | COMPUTERIZED SYSTEM FOR COMMUNICATING TREATMENT INFORMATION TO A USER | Non-Final OA | DIABELOOP |
| 16646705 | Ophthalmic Delivery Device | Non-Final OA | Oxular Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.0% of resolved applications examined by Antarius S Daniel were allowed (196 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +14.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Antarius S Daniel took 1,276 days on average from filing to allowance.
Antarius S Daniel examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
